Author

Vivi Kasim

Chongqing UniversityORCID 0000-0001-9182-8230Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Hezhao Zhao· 1 shared Ian Timothy Sembiring MelialaiD· 1 shared Makoto MiyagishiiD· 1 shared Mankun Wei· 1 shared Rendy HoseaiD· 1 shared Sharon Hillary· 1 shared Shourong WuiD· 1 shared Wei DuaniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Hezhao Zhao

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyAdvanced SciencePeer-reviewedApr 29, 2024

YY2/BUB3 axis-mediated SAC hyperactivity determines tumor cell fate through chromosomal instability

Rendy Hosea, Wei Duan, Ian Timothy Sembiring Meliala…·Vivi Kasim

This study identifies the YY2/BUB3 axis as a regulator of SAC activity and shows how SAC hyperactivity and CIN levels influence tumor cell fate and drug sensitivity.

18 citations

humanDNA methylation

𝕏 PostBluesky